XTL Biopharmaceuticals Ltd. (FRA:H2K2)
Germany · Delayed Price · Currency is EUR 0.6850
+0.0300 (4.58%)
At close: Jan 30, 2026
-54.33% (1Y)
| Market Cap | 6.94M -66.5% |
| Revenue (ttm) | 824.25K |
| Net Income | -5.37M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 132 |
| Open | 0.6550 |
| Previous Close | 0.6550 |
| Day's Range | 0.6550 - 0.6850 |
| 52-Week Range | 0.4440 - 4.0000 |
| Beta | n/a |
| RSI | 49.37 |
| Earnings Date | Mar 12, 2026 |